Outlook Therapeutics Cash Flow Statement (2015-2025) | OTLK

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income -13.98M-11.72M-18.06M-16.86M-3.54M-22.33M-10.57M-19.10M-8.05M-5.33M-6.37M-1.92M-7.54M-8.43M-12.20M-9.74M-10.24M-4.44M-10.10M-8.78M-5.70M-3.01M-46.36M-20.15M-13.29M-13.48M
Depreciation and Depletion 0.06M0.06M0.05M
Share-based Compensation 2.03M1.97M2.49M-4.45M10.57M3.83M2.46M2.33M2.12M1.66M1.89M-0.30M0.23M0.16M0.87M0.27M-0.03M0.20M0.36M0.30M1.36M3.67M1.70M1.67M1.82M0.88M
Gains from Sales and Divestitures 0.11M0.00M109.00109.00109.00
Gains from Investment Securities 2.60M0.07M0.03M0.81M-1.04M-3.75M0.82M-0.08M-0.21M0.06M0.18M-1.64M1.30M-1.93M-0.17M-0.20M-764.000.13M-40.27M-2.06M2.00M-2.68M2.79M
Asset Writedowns and Impairment 2.35M0.56M0.05M8.34M0.42M0.10M
Non-cash Items 2.49M3.31M2.43M2.11M6.50M4.80M3.13M2.02M4.31M
Cash from Operations -10.04M-11.01M-12.01M-7.06M-16.04M-10.37M-5.84M-4.11M-5.63M0.08M-8.67M-7.44M-8.54M-8.39M-9.78M-6.26M-10.31M-5.94M-6.67M-10.97M-16.58M-11.90M-12.38M-14.94M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges 0.00M0.00M0.00M0.00M0.00M0.00M0.14M0.84M1.33M1.70M0.58M0.39M0.23M0.12M0.45M0.44M0.42M0.02M0.12M0.10M
Depreciation & Amortization (CF) 0.42M0.96M0.59M0.60M0.60M0.60M0.67M0.68M0.67M0.67M0.68M0.73M0.82M0.82M0.82M0.82M0.83M0.89M0.18M0.06M0.05M0.03M0.03M0.03M0.03M0.03M
Change in Working Capital
Change in Receivables -1.00M-0.05M0.08M0.40M-0.50M-0.00M-0.26M-1.38M
Change in Inventory 3.11M0.50M0.52M-0.79M0.12M
Change in Account Payables -0.86M4.10M-0.23M2.11M-7.59M0.38M5.90M1.07M-0.31M-0.93M-6.95M0.04M-1.09M1.29M-0.26M0.49M-2.17M0.60M0.29M4.22M-4.63M2.04M0.03M-2.87M
Change in Accured Expenses 0.72M0.79M2.20M-1.89M2.98M-2.13M1.22M-0.03M0.20M-0.50M-2.56M-0.02M0.48M0.44M-1.42M0.64M-0.31M0.61M1.11M0.15M-0.99M2.20M0.35M-0.30M
Change in Taxes 0.03M0.01M0.05M0.05M
Other Working Capital Changes -0.49M-0.00M-0.49M-0.59M-0.40M-0.49M-2.23M-0.32M0.27M-0.33M0.79M-2.34M-0.74M-0.77M-1.05M-0.64M4.47M-10.93M-0.29M-5.63M-0.21M-0.33M-1.84M0.44M
Investing Activities
Capital Expenditures 3.49M3.29M0.36M-0.05M0.45M0.33M0.15M0.04M0.08M0.02M1.08M0.28M0.17M1.26M0.63M0.47M-0.05M-0.61M
Cash from Investing Activities -3.49M-3.29M-0.36M0.05M-0.45M-0.33M-0.15M-0.04M-0.08M-0.02M-1.08M-0.28M-0.17M-1.26M-0.24M-0.05M-0.15M-1.00
Financing Activities
Other financing activities 0.04M0.18M
Cash from Financing Activities 18.48M18.00M8.89M4.27M27.21M-0.50M5.72M2.16M5.77M2.99M20.40M-0.19M14.56M-0.42M8.53M6.24M24.33M-0.07M-0.01M1.74M18.44M13.25M11.56M15.53M
Additional items
Exchange Rate Effect 0.02M-0.01M0.01M
Change in Cash 4.95M3.69M-3.49M-2.74M10.71M-11.20M-0.27M-2.00M0.06M3.05M10.65M-7.90M5.86M-10.08M-1.49M-0.07M13.87M-6.01M-6.68M-9.22M1.85M1.34M-0.82M0.59M
Free Cash Flow -13.53M-14.31M-12.38M-7.01M-16.49M-10.70M-5.99M-4.15M-5.71M0.06M-9.75M-7.71M-8.70M-9.66M-10.41M-6.73M-10.26M-5.33M-6.67M-10.97M-16.58M-11.90M-12.38M-14.94M
Net Cash Flow 4.95M3.69M-3.49M-2.74M10.71M-11.20M-0.27M-2.00M0.06M3.05M10.65M-7.90M5.86M-10.08M-1.49M-0.07M13.87M-6.01M-6.68M-9.22M1.85M1.34M-0.82M0.59M